Hôpital Robert Schuman

At Hôpital Robert Schuman, clinical research in neoplasms focuses on cancers of the lung, colon, and pancreas, with studies aimed at improving treatment effectiveness and long-term outcomes for people living with advanced or resected disease.

• Maintenance approaches for non-small cell lung cancer are being evaluated to see whether adding or continuing treatment can improve control of the disease after initial therapy.
• Research in colon carcinoma is exploring how circulating tumor DNA can help guide adjuvant treatment decisions and support better disease-free survival.
• Studies in pancreatic ductal adenocarcinoma are examining maintenance strategies to assess survival benefits in locally advanced or metastatic disease.

These trials reflect a strong focus on testing new treatment strategies and refining how cancer care is delivered for patients with digestive and thoracic tumors.

The site also supports research in immune-mediated disease, especially conditions where controlling inflammation while reducing steroid exposure is an important goal.

• In eosinophilic granulomatosis with polyangiitis, investigators are studying whether a mepolizumab-based approach can help induce remission and limit the need for corticosteroids.
• This work is centered on improving symptom control and offering more targeted options for patients with relapsing or newly diagnosed inflammatory disease.

The research highlights a broader interest in immune system processes and in finding safer, more effective ways to manage chronic inflammatory disorders.

The service de pneumologie is involved in studies of advanced lung cancer, with a particular emphasis on KRAS G12C-mutant non-small cell lung cancer and the search for better treatment combinations.

• Trials are testing whether new targeted approaches can improve outcomes when paired with established immunotherapy for patients with advanced disease.
• Research is also looking at treatment options after surgery or when tumors cannot be removed, with the goal of strengthening disease control.
• These studies aim to evaluate the effectiveness of promising therapies for people with hard-to-treat lung tumors.

This portfolio shows a clear commitment to advancing thoracic oncology through more precise and potentially more effective treatment strategies.

Another active area at the site concerns digestive cancer surgery, where studies are assessing ways to improve recovery and reduce complications around the time of surgery.

• Research is examining whether preoperative corticosteroid use can lower the risk of major complications after curative-intent surgery.
• The goal is to make surgical treatment safer and support better short-term outcomes for patients undergoing complex cancer operations.

This work connects oncology with perioperative medicine, focusing on practical ways to improve care for people with digestive malignancies.